Eco R1 Capital, LLC Rocket Pharmaceuticals, Inc. Transaction History

Eco R1 Capital, LLC

  • $2.31 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$20.66 - $26.72 $10.5 Million - $13.6 Million
508,393 New
508,393 $10.9 Million
Q2 2019

Aug 14, 2019
SELL
$15.0 - $19.81 $6.75 Million - $8.91 Million
-450,000 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$11.21 - $23.53 $5.04 Million - $10.6 Million
450,000 New
450,000 $6.67 Million

Others Institutions Holding RCKT

# of Institutions
209
Shares Held
93.2M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $890M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email